Quoin Pharmaceuticals Analyst Price Targets

Wall Street analyst price targets and consensus rating for Quoin Pharmaceuticals (QNRX).

Price Target Range — 4 Quarters

Analyst Consensus — 5 Analysts

5Buy

Consensus RatingBuy# Analysts5Avg. Consensus PT$21Upside to Avg. PT+429.7%

Rating Trend — Last 9 Months

Recent Analyst Actions

すべての評価を見る →

Date	Firm	Analyst	Action	Rating Change	Price Target
Oct 19, 2026	Canaccord Genuity	Whitney Ijem	Initiate	Buy	$18
Oct 12, 2026	BTIG	Jeet Mukherjee	Initiate	Buy	$14
Sep 23, 2026	Lake Street	Thomas Flaten	Initiate	Buy	$20
May 4, 2026	LUCID CAPITAL MARKETS	Dev Prasad	Initiate	Buy	$30
Mar 15, 2024	Maxim Group	Naz Rahman	PT Cut	Buy	$525→$140

Analyst Ratings News

PRO
Canaccord Genuity Initiates Coverage On Quoin Pharmaceuticals with Buy Rating, Announces Price Target of $18

Canaccord Genuity analyst Whitney Ijem initiates coverage on Quoin Pharmaceuticals (NASDAQ:QNRX) with a Buy rating and announces Price Target of $18.

Benzinga Newsdesk

This Robinhood Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Monday

Analysts initiated coverage on ASBH, QNRX, AXGN and HOOD with bullish ratings and targets; IDXX received a Sector Weight rating.

Avi Kapoor

PRO
BTIG Initiates Coverage On Quoin Pharmaceuticals with Buy Rating, Announces Price Target of $14

BTIG analyst Jeet Mukherjee initiates coverage on Quoin Pharmaceuticals (NASDAQ:QNRX) with a Buy rating and announces Price Target of $14.

Benzinga Newsdesk

PRO
Lake Street Initiates Coverage On Quoin Pharmaceuticals with Buy Rating, Announces Price Target of $20

Lake Street analyst Thomas Flaten initiates coverage on Quoin Pharmaceuticals (NASDAQ:QNRX) with a Buy rating and announces Price Target of $20.

Benzinga Newsdesk

PRO
LUCID CAPITAL MARKETS Initiates Coverage On Quoin Pharmaceuticals with Buy Rating, Announces Price Target of $30

LUCID CAPITAL MARKETS analyst Dev Prasad initiates coverage on Quoin Pharmaceuticals (NASDAQ:QNRX) with a Buy rating and announces Price Target of $30.

Benzinga Newsdesk

Maxim Group Maintains Buy Rating for Quoin Pharmaceuticals: Here's What You Need To Know

Benzinga Insights

Quoin Pharmaceuticals Ltd

ニュース

パートナーシップ

ベンジンガ・グローバル

Quoin Pharmaceuticals Analyst Price Targets

Recent Analyst Actions

Analyst Ratings News

PRO
Canaccord Genuity Initiates Coverage On Quoin Pharmaceuticals with Buy Rating, Announces Price Target of $18

This Robinhood Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Monday

PRO
BTIG Initiates Coverage On Quoin Pharmaceuticals with Buy Rating, Announces Price Target of $14

PRO
Lake Street Initiates Coverage On Quoin Pharmaceuticals with Buy Rating, Announces Price Target of $20

PRO
LUCID CAPITAL MARKETS Initiates Coverage On Quoin Pharmaceuticals with Buy Rating, Announces Price Target of $30

Maxim Group Maintains Buy Rating for Quoin Pharmaceuticals: Here's What You Need To Know

People Also Watch

People Also Watch

Quoin Pharmaceuticals Ltd

ニュース

パートナーシップ

ベンジンガ・グローバル

Quoin Pharmaceuticals Analyst Price Targets

Recent Analyst Actions

Analyst Ratings News

PROCanaccord Genuity Initiates Coverage On Quoin Pharmaceuticals with Buy Rating, Announces Price Target of $18

This Robinhood Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Monday

PROBTIG Initiates Coverage On Quoin Pharmaceuticals with Buy Rating, Announces Price Target of $14

PROLake Street Initiates Coverage On Quoin Pharmaceuticals with Buy Rating, Announces Price Target of $20

PROLUCID CAPITAL MARKETS Initiates Coverage On Quoin Pharmaceuticals with Buy Rating, Announces Price Target of $30

Maxim Group Maintains Buy Rating for Quoin Pharmaceuticals: Here's What You Need To Know

People Also Watch

People Also Watch

PRO
Canaccord Genuity Initiates Coverage On Quoin Pharmaceuticals with Buy Rating, Announces Price Target of $18

PRO
BTIG Initiates Coverage On Quoin Pharmaceuticals with Buy Rating, Announces Price Target of $14

PRO
Lake Street Initiates Coverage On Quoin Pharmaceuticals with Buy Rating, Announces Price Target of $20

PRO
LUCID CAPITAL MARKETS Initiates Coverage On Quoin Pharmaceuticals with Buy Rating, Announces Price Target of $30